购物车
- 全部删除
- 您的购物车当前为空
IR415 选择性地与 HBx 相互作用 (Kd=2 nM) 并阻断 HBV 介导的 RNAi 抑制,逆转 HBx 蛋白对 Dicer 核糖核酸内切酶活性的抑制作用。IR415 具有抗 HBV 的活性。
为众多的药物研发团队赋能,
让新药发现更简单!
IR415 选择性地与 HBx 相互作用 (Kd=2 nM) 并阻断 HBV 介导的 RNAi 抑制,逆转 HBx 蛋白对 Dicer 核糖核酸内切酶活性的抑制作用。IR415 具有抗 HBV 的活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 170 | 现货 | |
5 mg | ¥ 387 | 现货 | |
10 mg | ¥ 690 | 现货 | |
25 mg | ¥ 1,390 | 现货 | |
50 mg | ¥ 2,390 | 现货 | |
100 mg | ¥ 3,400 | 现货 | |
200 mg | ¥ 4,730 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 437 | 现货 |
产品描述 | IR415 selectively interacts with Hepatitis B virus X protein (HBx, Kd = 2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBx protein on the activity of the dicer endoribonuclease. IR415 is a potent anti-HBV agent and inhibits HBV replication by blocking the HBx activity. |
靶点活性 | HBx:2 nM(Kd) |
体外活性 | IR415 (50-200 μM) has a dose-dependent inhibitory effect on HBx, with a minimal effective concentration of 50 μM in HepG2/GFP-shRNA line transfected with HBx.Hepatitis B virus X protein (HBx) as a suppressor of host defenses consisting of RNAi-based silencing of viral genes. |
分子量 | 296.34 |
分子式 | C13H14F2N4S |
CAS No. | 452967-14-5 |
Smiles | Fc1ccc(NC(=S)NCCCn2ccnc2)c(F)c1 |
密度 | 1.32 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 125 mg/mL (421.81 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容